$SLGN

Silgan Holdings’ Q2 2026 earnings call covered segment performance and margin pressure. Management said Dispensing and Specialty Closures strength in fine fragrance was offset by lower operating margins and softer Brazil conditions, including a 15% Brazil volume decline. CEO Adam Greenlee cited cost inflation management, contractual visibility for 2027, and expected Brazil recovery in late Q3. SLGN trades at $42.32.

Simply Wall St reports Silgan Holdings (SLGN) reaffirmed its quarterly cash dividend of $0.21 per share, with a Sept. 1, 2026 record date and Sept. 15, 2026 payment date. The stock at $42.32 is down 11.85% over 7 days and 8.77% over 30 days. A narrative estimates fair value at $54.77, about 23% above the last close.

Silgan Holdings (SLGN) reported Q2 2026 adjusted EPS of 98 cents, above the Zacks consensus of 96 cents. Net revenue rose 6.8% to $1.64 billion. Gross margin fell to 17.9%. The company reaffirmed 2026 adjusted earnings guidance of $3.73-$3.93 per share and free cash flow of $450 million.

Strategic Performance Drivers Management attributed Q2 performance to strong execution in high-value segments like fine fragrance and wet pet food, which helped offset geopolitical and inflationary headwinds. Dispensing and Specialty Closures (DSC) faced a 15% volume decline in Brazil due to inflationary market conditions, though management views this as a temporary market dynamic rather than a loss of share.

United States / Packaging / NYSE:SLGN Silgan Holdings (SLGN) Stock Faces Margin Squeeze Despite Reaffirmed Outlook July 30, 2026 Silgan Holdings stock came into today on the back foot after a 3.6% slide to about US$41, even as fresh earnings presented a more balanced picture. The market reacted to the headline drop in quarterly earnings per share, yet the core story was a packaging business that kept revenue at roughly US$1.6b and reaffirmed full year guidance.

Fabry said the combination of Brazil volume weakness and less favorable mix reduced second-quarter results by about $5 million. Despite that impact, adjusted EBIT in the segment was comparable with the prior year as favorable price over cost offset the volume and mix pressure. Greenlee highlighted continued strong growth in fine-fragrance dispensing products, particularly in Europe.

Silgan has posted a net income of $75.8m for the second quarter (Q2) of 2026, down from $89m in the same period of 2025. Quarterly sales reached $1.64bn, an increase of $104.1m, or 7%, from a year earlier. Discover B2B Marketing That Performs Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Silgan (SLGN) held its Q2 2026 earnings call, reporting net sales of about $1.6 billion, up 7% year over year, and adjusted EPS of $0.98. Adjusted EPS was below the prior year due to lower adjusted EBIT. The company confirmed 2026 adjusted EPS guidance of $3.73 to $3.93 and gave Q3 2026 adjusted EPS guidance of $1.21 to $1.31.

SILGAN HOLDINGS INC (SLGN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a991_63026.htm EX-99.1 Document Silgan Holdings Inc. Exhibit 99.1 SILGAN ANNOUNCES SECOND QUARTER 2026 RESULTS H ighlights • Achieved high single digit volume growth in dispensing products for fragrance markets • Delivered high single digit volume growth in metal contai

Silgan Holdings (NYSE:SLGN) reported Q2 CY2026 results with revenue up 6.8% year on year to $1.64 billion, topping Wall Street’s revenue estimate by 1.9%, according to the company and consensus. Non-GAAP adjusted EPS was $0.98, 1.9% above analysts’ estimates. Full-year EPS guidance is expected to rise from $3.65 to $3.91.